Biotech M&A Ratchets Up to a New Level

Cassava Sciences Inc (NASDAQ: SAVA) shares have tumbled to their lowest level since mid-December 2019 after the company issued an adverse clinical readout. read more.....»»

Ask the hoards of biotech and medical device industry workers coming out of the Kendall Square T station on any given morning how they feel about the local transportation — be it a 20-something, entry-level employee or an executive in their mid-50s .....»»

Ask the hoards of biotech and medical device industry workers coming out of the Kendall Square T station on any given morning how they feel about the local transportation — be it a 20-something, entry-level employee or an executive in their mid-50s .....»»

Shares of the mid-cap biotech Amarin Corporation plc (NASDAQ: AMRN) were pulling back to their lowest level since early January on Friday. read more.....»»

Gemphire Therapeutics Inc (NASDAQ: GEMP) stock — which has been on a broader downtrend since mid-2017 — was advancing strongly Thursday.  read more.....»»

Small-cap biotech Cara Therapeutics Inc (NASDAQ: CARA) is trading to its highest level since early April after it released the results of a Phase 3 trial for its lead candidate Korsuva. read more.....»»

Shares of small-cap oncology biotech Puma Biotechnology Inc (NASDAQ: PBYI) are sinking to their lowest level since November following the release of its first-quarter results. read more.....»»

A new Cambridge startup hopes to take research of the microbiome to next level, emerging from stealth mode Tuesday with plans to bring multiple drugs to the clinic and "recruit aggressively" over the next year. Flagship Pioneering's new startup Kin.....»»

We screened our 24/7 Wall St. research database and found five biotech stocks trading under the $10 level that could provide investors with some solid upside potential......»»

Here are five biotech stocks that are rated Buy by the Jefferies analysts, are trading under the $10 level and could provide investors with some solid upside potential......»»

Puma Biotechnology Inc (NASDAQ: PBYI), a company focused on developing cancer drugs, is seeing its stock hurtle to its lowest level in about 2 1/2 years following the release Latest Ratings for PBYI DateFirm.....»»

These five stocks trading under the $10 level have big upside to the analysts' price targets. Plus they are all covered with Buy ratings at top firms across Wall Street......»»

The Watertown startup has an ambitious goal of developing vaccines that provide lifelong protection from cancer and infectious diseases......»»

As South Florida continues to attract residents and businesses alike and with rising concerns over climate change, sea-level rise, and environmental degradation, the necessity for sustainable construction practices has never been more pressing. South Flor.....»»

Merchants Insurance Group has announced four internal officer-level promotions at its corporate headquarters in downtown Buffalo, New York. Dawn Malek — director, human resources Under her new title of director, human resources, Dawn Male.....»»

Iran's Oil Exports Climb To The Highest Level In.....»»

California's massive budget deficit, coupled with the state's relatively high level of joblessness, has become a major barrier to reducing the billions of dollars of debt it ha.....»»

The new roles come months after the Federal Deposit Insurance Corp. issued a consent order to First Fed due to a partnership the bank had with a fintech company......»»

Shares of U.S. financial companies have negatively responded to the flood of recent earnings reports for the sector, mirroring the market’s subdued sentiment due to g.....»»

Top Stories for April 16, 2024: 1. Gold Resource (NYSE:GORO) repor.....»»